Esophagus Cancer Completed Phase 2 Trials for Mitomycin (DB00305)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00201747Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach CancerTreatment